102029-87-8,
Adp Di(monocyclohexylammonium) salt,
MFCD00058338,
AK111487,
Cyclohexanamine (((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate) (2:1),
Adenosine 5'-diphosphate bis(cyclohexylammonium) salt,
ST24046386,
C-46179,
Adenosine 5-diphosphate bis(cyclohexylammonium) salt,
Adenosine 5 inverted exclamation marka-diphosphate bis(cyclohexylammonium) salt,
Adenosine 5'-diphosphate bis(cyclohexylammonium) salt, >=95% (HPLC), crystalline, bacterial,
cyclohexanamine hemi(((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl diphosphate),
ADP,
Cyclohexanaminium ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl hydrogendiphosphate,
Cyclohexanaminium((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methylhydrogendiphosphate,